Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-088497
Filing Date
2025-06-20
Accepted
2025-06-20 16:05:35
Documents
1
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4233
  Complete submission text file 0000950170-25-088497.txt   5886
Mailing Address C/O IGNYTA, INC. 11095 FLINTKOTE AVE., SUITE D SAN DIEGO CA 92121
Business Address
Chacko Jacob (Reporting) CIK: 0001608936 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39782 | Film No.: 251061331

Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Issuer) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)